Karyopharm Therapeutics, Inc. | TalkMarkets | Page 1
No data available
No data available

People who follow this stock (43)

View All

Latest Posts

About This Stock More About This Stock
10 Best Medical Stocks Under $5
Article By: Insider Monkey
Saturday, October 29, 2022 4:34 PM EDT
The medical industry is one of the most lucrative sectors globally, and it is one that sees the highest spending in terms of research and development, and breakthrough advances through keeping up the pace with technology.
In this article: GERN, HOOK, AGEN, CTIC, KPTI, VSTM, ARDX, TTOO, XERS, ZOM
Read
Week In Review: GenScript And Its Legend Bio Subsidiary Raise $1 Billion From Hillhouse
Article By: ChinaBio® Today
Saturday, May 15, 2021 1:39 PM EDT
GenScript raised more than $1 billion from Hillhouse Capital in several different investments, including a $500 million commitment to GenScript's Legend Biotech CAR-T subsidiary. Before the investments, Legend was worth $4 billion.
In this article: BIDU, KPTI, FLGT, BNTX, LEGN
Read
This Revolutionary Sector Is Transforming The Market Itself – Here’s How You Can Cash In On It
Article By: Michael A. Robinson
Wednesday, September 30, 2020 5:20 AM EDT
The Nasdaq is now committed to moving most of its 28 markets online by 2025, and all of them by 2030. I think that’s a conservative estimate. In the very near future, I believe all markets will reside in the cloud.
In this article: NDAQ Also: SKYY, AMZN, MSFT, GOOGL, AZN, GSK, KMB, NVS, SAP, BAYRY, AVGO, CLVS, WORK, NOW, VEEV, KPTI, FSLY
Read
Week In Review: Antengene Approved By Hong Kong Exchange For $200 Million IPO
Article By: ChinaBio® Today
Saturday, August 29, 2020 12:43 PM EDT
Antengene, a three-year old Shanghai startup originally backed by Celgene, will conduct a Hong Kong IPO that is expected to raise $200 million. BeiGene acquired China rights to Bio-Thera's Avastin® biosimilar in an agreement worth up to $165 million.
In this article: AZN, SVA, KPTI, SFOSF, BGNE, BNTX, PFE, LBTSF
Read
Healthcare & Biotechs Struggle, But Opportunity Ahead
Article By: Tarun Chandra, CFA
Wednesday, October 23, 2019 2:24 AM EDT
Improving risk appetite is nudging markets higher, and biotechs will participate as well, although gains will have a ceiling.
In this article: ACAD, ARQL, MNTA, SGEN, MDCO, ARWR, KPTI, RDUS, FLXN, RETA, ZYME, DRNA, TCDA, DCPH, APLS, ACHN, ALXN, VRTX, ALDR, RARX, DOVA
Read
All Posts

Latest Tweets for $KPTI

No tweets yet!

PARTNER HEADLINES